Why have drugs to treat the liver disease MASH reached a tipping point? How did Hims & Hers convince Childish Gambino to ...

Weight-loss drugs are transforming both health care and Wall Street, with leading manufacturers like Eli Lilly & Co. (LLY) ...

A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.

Here’s what to know about ultra-processed foods, and how Kennedy has said he plans to shape the U.S. food system.

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

There’s no “perfect” or “better” body shape, experts agree — yet you still might find yourself wondering what your body shape ...

Seniors whose cholesterol levels spike and plummet year-to-year could be at increased risk of dementia and failing brain ...

Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...

New research shows bariatric surgery's powerful impact on liver health, reducing fatty liver disease risk and improving ...

Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period, which included revenue from its domestic branded formulation ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...